These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 35990887)

  • 1. Regulation of N6-methyladenosine (m6A) RNA methylation in microglia-mediated inflammation and ischemic stroke.
    Zhang F; Ran Y; Tahir M; Li Z; Wang J; Chen X
    Front Cell Neurosci; 2022; 16():955222. PubMed ID: 35990887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamics of N6-methyladenosine modification during Alzheimer's disease development.
    Gao S; Wang Y; Li X; Liang Y; Jin Z; Yang B; Yuan TF; Tian H; Peng B; Rao Y
    Heliyon; 2024 Mar; 10(6):e26911. PubMed ID: 38496847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of N6-methyladenosine modification in central nervous system diseases and related therapeutic agents.
    Lv J; Xing L; Zhong X; Li K; Liu M; Du K
    Biomed Pharmacother; 2023 Jun; 162():114583. PubMed ID: 36989722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Search of a Function for the N6-Methyladenosine in Epitranscriptome, Autophagy and Neurodegenerative Diseases.
    Suga N; Ikeda Y; Yoshikawa S; Taniguchi K; Sawamura H; Matsuda S
    Neurol Int; 2023 Aug; 15(3):967-979. PubMed ID: 37606395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential role of N6-methyladenosine modification in the development of Parkinson's disease.
    Zhou J; Han Y; Hou R
    Front Cell Dev Biol; 2023; 11():1321995. PubMed ID: 38155838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of m6A modification in neurological diseases.
    Zhang Y; Zhang S; Shi M; Li M; Zeng J; He J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jan; 47(1):109-115. PubMed ID: 35545370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. m6A Reader Igf2bp1 Regulates the Inflammatory Responses of Microglia by Stabilizing
    Ding L; Wu H; Wang Y; Li Y; Liang Z; Xia X; Zheng JC
    Front Immunol; 2022; 13():872252. PubMed ID: 35572575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N6-methyladenosine RNA modification: A promising regulator in central nervous system injury.
    Wang Q; Liang Y; Luo X; Liu Y; Zhang X; Gao L
    Exp Neurol; 2021 Nov; 345():113829. PubMed ID: 34339678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of N6-methyladenosine modification in pathogenesis of ischemic stroke.
    Chang H; Yang J; Wang Q; Zhao J; Zhu R
    Expert Rev Mol Diagn; 2022 Mar; 22(3):295-303. PubMed ID: 35236212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptome and N6-Methyladenosine RNA Methylome Analyses in Aortic Dissection and Normal Human Aorta.
    Zhou X; Chen Z; Zhou J; Liu Y; Fan R; Sun T
    Front Cardiovasc Med; 2021; 8():627380. PubMed ID: 34124185
    [No Abstract]   [Full Text] [Related]  

  • 11. N6-methyladenosine and Neurological Diseases.
    Zhang N; Ding C; Zuo Y; Peng Y; Zuo L
    Mol Neurobiol; 2022 Mar; 59(3):1925-1937. PubMed ID: 35032318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory Role of N6-Methyladenosine (m6A) Modification in Osteoarthritis.
    Zhai G; Xiao L; Jiang C; Yue S; Zhang M; Zheng J; Liu Z; Dong Y
    Front Cell Dev Biol; 2022; 10():946219. PubMed ID: 35846376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration of N6-methyladenosine modification profiles in the neutrophilic RNAs following ischemic stroke.
    Fan J; Zhong L; Yan F; Li X; Li L; Zhao H; Han Z; Wang R; Tao Z; Zheng Y; Ma Q; Luo Y
    Neuroscience; 2024 Jun; 553():56-73. PubMed ID: 38945353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of m6A RNA Methylation in Ischemic Stroke.
    Xu Y; Liu W; Ren L
    Mol Neurobiol; 2024 Feb; ():. PubMed ID: 38363537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging Roles and Mechanism of m6A Methylation in Cardiometabolic Diseases.
    Xu Z; Lv B; Qin Y; Zhang B
    Cells; 2022 Mar; 11(7):. PubMed ID: 35406663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crosstalk among N6-methyladenosine modification and RNAs in central nervous system injuries.
    Tian M; Mao L; Zhang L
    Front Cell Neurosci; 2022; 16():1013450. PubMed ID: 36246528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Insights Into the Role of N6-Methyladenosine RNA Modification in Bone Pathophysiology.
    Chen J; Tian Y; Zhang Q; Ren D; Zhang Q; Yan X; Wang L; He Z; Zhang W; Zhang T; Yuan X
    Stem Cells Dev; 2021 Jan; 30(1):17-28. PubMed ID: 33231507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. m6A methylation: Critical roles in aging and neurological diseases.
    Fan Y; Lv X; Chen Z; Peng Y; Zhang M
    Front Mol Neurosci; 2023; 16():1102147. PubMed ID: 36896007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversible N6-methyladenosine of RNA: The regulatory mechanisms on gene expression and implications in physiology and pathology.
    Fang X; Li M; Yu T; Liu G; Wang J
    Genes Dis; 2020 Dec; 7(4):585-597. PubMed ID: 33335958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between the network of non-coding RNAs-molecular targets and N6-methyladenosine modification in tumors of urinary system.
    Li R; Zhu C; Wang Y; Wang X; Wang Y; Wang J; Wang K
    Cell Death Dis; 2024 Apr; 15(4):275. PubMed ID: 38632251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.